Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; University Vita-Salute San Raffaele, Milan, Italy; Department of Urology, IRCCS European Institute of Oncology (IEO), Milan, Italy.
Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; University Vita-Salute San Raffaele, Milan, Italy.
Eur Urol Focus. 2024 Jan;10(1):98-106. doi: 10.1016/j.euf.2023.07.010. Epub 2023 Aug 10.
Male infertility has been associated with increased morbidity and mortality.
To perform a systematic review and meta-analysis to provide the most critical evidence on the association between infertility and the risk of incident comorbidities in males.
A systematic review and meta-analysis was performed according to the Meta-analysis of Observational Studies in Epidemiology and Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines, and registered on PROSPERO. All published studies on infertile versus fertile men regarding overall mortality and risks of cancer, diabetes, and cardiovascular events were selected from a database search on PubMed, EMBASE, Google Scholar, and Cochrane. Forest plot and quasi-individual patient data meta-analysis were used for pooled analyses. A risk of bias was assessed using the ROBINS-E tool.
Overall, an increased risk of death from any cause was found for infertile men (hazard risk [HR] 1.37, [95% confidence interval {CI} 1.04-1.81], p = 0.027), and a 30-yr survival probability of 91.0% (95% CI 89.6-92.4%) was found for infertile versus 95.9% (95% CI 95.3-96.4%) for fertile men (p < 0.001). An increased risk emerged of being diagnosed with testis cancer (relative risk [RR] 1.86 [95% CI 1.41-2.45], p < 0.001), melanoma (RR 1.30 [95% CI 1.08-1.56], p = 0.006), and prostate cancer (RR 1.66 [95% CI 1.06-2.61], p < 0.001). As well, an increased risk of diabetes (HR 1.39 [95% CI 1.09-1.71], p = 0.008), with a 30-yr probability of diabetes of 25.0% (95% CI 21.1-26.9%) for infertile versus 17.1% (95% CI 16.1-18.1%) for fertile men (p < 0.001), and an increased risk of cardiovascular events (HR 1.20 [95% CI 1.00-1.44], p = 0.049), with a probability of major cardiovascular events of 13.9% (95% CI 13.3-14.6%) for fertile versus 15.7% (95% CI 14.3-16.9%) for infertile men (p = 0.008), emerged.
There is statistical evidence that a diagnosis of male infertility is associated with increased risks of death and incident comorbidities. Owing to the overall high risk of bias, results should be interpreted carefully.
Male fertility is a proxy of general men's health and as such should be seen as an opportunity to improve preventive strategies for overall men's health beyond the immediate reproductive goals.
男性不育与发病率和死亡率的增加有关。
进行系统评价和荟萃分析,提供有关男性不育与新发合并症风险之间关联的最关键证据。
根据观察性研究荟萃分析的流行病学和系统评价和荟萃分析的首选报告项目指南,进行系统评价和荟萃分析,并在 PROSPERO 上注册。从 PubMed、EMBASE、Google Scholar 和 Cochrane 数据库搜索中选择了所有关于不育男性与生育男性的总体死亡率以及癌症、糖尿病和心血管事件风险的已发表研究。使用森林图和准个体患者数据荟萃分析进行汇总分析。使用 ROBINS-E 工具评估风险偏倚。
总体而言,不育男性的任何原因死亡风险增加(风险比 [HR] 1.37,[95%置信区间 {CI} 1.04-1.81],p=0.027),不育男性的 30 年生存率为 91.0%(95%CI 89.6-92.4%),而生育男性的 30 年生存率为 95.9%(95%CI 95.3-96.4%)(p<0.001)。诊断为睾丸癌(相对风险 [RR] 1.86 [95% CI 1.41-2.45],p<0.001)、黑色素瘤(RR 1.30 [95% CI 1.08-1.56],p=0.006)和前列腺癌(RR 1.66 [95% CI 1.06-2.61],p<0.001)的风险增加。同样,糖尿病的风险增加(HR 1.39 [95% CI 1.09-1.71],p=0.008),不育男性的 30 年糖尿病概率为 25.0%(95%CI 21.1-26.9%),而生育男性的 30 年糖尿病概率为 17.1%(95%CI 16.1-18.1%)(p<0.001),心血管事件的风险增加(HR 1.20 [95% CI 1.00-1.44],p=0.049),生育男性主要心血管事件的概率为 13.9%(95%CI 13.3-14.6%),而不育男性主要心血管事件的概率为 15.7%(95%CI 14.3-16.9%)(p=0.008)。
有统计学证据表明,男性不育症的诊断与死亡和新发合并症风险的增加有关。由于整体高风险偏倚,结果应谨慎解释。
男性生育能力是男性整体健康的代表,因此应将其视为改善男性整体健康预防策略的机会,而不仅仅是生殖方面的直接目标。